China Pharma Holdings (CPHI) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Price: $1.13 +3.67%
Financial Fact:
Total operating expenses: 1.9M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 1.9M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $19.6 million versus the consensus estimate of $19.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
